![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 403/04 | |
C07D 487/04 | |||
C07D 491/04 | |||
C07D 495/04 | |||
A61K 31/405 | |||
A61P 35/00 | |||
A61K 31/06 |
(11) | Number of the document | 2549868 |
(13) | Kind of document | T |
(96) | European patent application number | 11760102.1 |
Date of filing the European patent application | 2011-03-23 | |
(97) | Date of publication of the European application | 2013-01-30 |
(45) | Date of publication and mention of the grant of the patent | 2015-01-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/029511 |
Date | 2011-03-23 |
(87) | Number | WO 2011/119663 |
Date | 2011-09-29 |
(30) | Number | Date | Country code |
317476 P | 2010-03-25 | US | |
352863 P | 2010-06-09 | US | |
381480 P | 2010-09-10 | US | |
388151 P | 2010-09-30 | US | |
419068 P | 2010-12-02 | US |
(72) |
AXTEN, Jeffrey, Michael, US
GRANT, Seth, Wilson, US
HEERDING, Dirk, A., US
MEDINA, Jesus, Raul, US
ROMERIL, Stuart, Paul, US
TANG, Jun, US
|
(73) |
GlaxoSmithKline LLC,
Corporation Service Company 2711 Centreville Road Suite 400, Wilmington, Delaware 19808,
US
|
(54) | CHEMICAL COMPOUNDS |
CHEMICAL COMPOUNDS |